Showing results (301-310 of 395) with videos related to
Sort By:
Pageof 40
Geospatial Health|November 20, 2018
Dispersal of harmful fruit fly pests by international trade and a loop-mediated isothermal amplification assay to prevent their introductionSimon Blaser, Cornelia Heusser, Hanspeter Diem, et al.Vaccine|August 7, 2013
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspASharon E Frey, Kathleen R Lottenbach, Heather Hill, et al.Pediatric Emergency Care|May 2, 2020
Videography in Pediatric Emergency Research: Establishing a Multicenter Collaborative and Resuscitation RegistryBenjamin T Kerrey, Karen J OʼConnell, Sage R Myers, et al.The Journal of Infectious Diseases|October 9, 1999
Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccineS E Frey, C Harrison, R F Pass, et al.Plos One|February 15, 2013
Comparative genomics of 12 strains of Erwinia amylovora identifies a pan-genome with a large conserved coreRachel A Mann, Theo H M Smits, Andreas Bühlmann, et al.Frontiers in Oncology|February 21, 2024
Immunotherapy utilization in stage IIIA melanoma: less may be moreAlexander E Frey, Daniel M Kerekes, Sajid A Khan, et al.Journal of Medical Genetics|September 23, 2008
Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophyD Araújo-Vilar, G Lattanzi, B González-Méndez, et al.Journal of Bacteriology|March 1, 2012
Complete genome sequence of clinical isolate Pantoea ananatis LMG 5342Pieter De Maayer, Wai Yin Chan, Fabio Rezzonico, et al.Clinical and Experimental Immunology|November 1, 1994
HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, D H Schwartz, B S Graham, et al.Vaccine|November 27, 2007
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challengeSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.Pageof 40